IGM Biosciences, Inc. Total Liabilities
IGM Biosciences, Inc. had Total Liabilities of $6.06 million as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-07-31
- 2025-06-30: Liabilities $6.06M.
- 2025-03-31: Liabilities $206.19M.
- 2024-12-31: Liabilities $217.54M.
- 2024-09-30: Liabilities $225.56M.
| Period end | Liabilities |
|---|---|
| 2025-06-30 | $6.06M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $206.19M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $217.54M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $225.56M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $214.14M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $214.88M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $220.18M 10-K · filed 2025-03-06 |
| 2023-09-30 | $220.49M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $222.05M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $223.31M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $226.24M 10-K · filed 2024-03-07 |
| 2022-09-30 | $212.76M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $206.79M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $53.22M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $53.22M 10-K · filed 2023-03-30 |
| 2021-09-30 | $46.65M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $28.21M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $24.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.82M 10-K · filed 2022-03-29 |
| 2020-09-30 | $23.54M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $22.10M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $19.14M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $21.12M 10-K · filed 2021-03-30 |
| 2019-09-30 | $15.23M 10-Q · filed 2019-11-07 |
| 2018-12-31 | $8.89M 10-K · filed 2020-03-26 |